Altor Fund IV and Goldman Sachs Merchant Banking Division have partnered to acquire the majority of Hamlet Protein from Polaris Private Equity and company founder Ole K. Hansen.
Hamlet Protein is a global provider of soy-based protein solutions used in animal feed for young animals. The company services more than 50 countries from its two production facilities in Horsens, Denmark and Findlay, Ohio.
"This is another important milestone for Hamlet Protein and we are very excited about our new partnership with Altor and Goldman Sachs Merchant Banking Division," Hamlet chief executive officer Soren Munch said. "With the strong support of Altor and Goldman Sachs, we are uniquely positioned to accelerate the development and growth of Hamlet Protein and better service our customers and partners globally."
Under the majority ownership of Polaris, the company "made a successful management succession and turned Hamlet Protein into a leading global provider of specialty soy for young animal feed with a strong market position in Europe, U.S. and Asia through developing global sales organization and significant investments in expanding capacity including establishing a sales and production facility in the U.S.," explained Polaris partner Niels Worning.
Altor is "looking forward" to the further development of Hamlet, which is "ideally positioned" in the young animal feed sector, Altor partner Soren Johansen said.
Michael Specht Bruun, managing director of the Goldman Sachs Merchant Banking Division, said, "We see significant growth potential globally and are excited about partnering with Altor and the management team to support the company's impressive growth trajectory both organically and through acquisitions."
Closing of the transaction is subject to customary regulatory requirements and approvals.
Hamlet's products provide nutritional and functional benefits by increasing palatability, digestibility and supporting gut health, which enables farmers to improve animal health and growth leading to enhanced protein output.